机构:[1]Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College,[2]Shandong Province Cancer Hospital, Ji’nan,[3]The Fourth Hospital of Hebei Medical University, Shijiazhuang,河北医科大学第四医院[4]Beijing Cancer Hospital,Capital Medical University[5]Tianjin Medical University Cancer Institute & Hospital, Tianjin,[6]Daping Hospital, The Third Military Medical University, Chongqing,[7]Yunnan Province Cancer Hospital, Kunming,[8]Shanghai Chest Hospital, Shanghai Jiaotong University,[9]Peking Union Medical College Hospital, Capital Medical University[10]Beijing Xuanwu Hospital, Capital Medical University,首都医科大学宣武医院[11]West China Hospital of Sichuan University, Chengdu,四川大学华西医院[12]Jiangsu Cancer Hospital, Nanjing,[13]The First Hospital of China Medical University, Shenyang[14]The 307th Hospital of Chinese People’s Liberation Army,[15]Huazhong University of Science and Technology Union Hospital, Wuhan,华中科技大学同济医学院附属协和医院[16]Chinese People’s Liberation Army General Hospital,[17]The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an,[18]The First Hospital of Jilin University,Changchun,[19]Harbin Medical University Cancer Hospital, Harbin,[20]Xinqiao Hospital of The Third Military Medical University, Chongqing,[21]Sichuan Cancer Hospital, Chengdu, ,四川省肿瘤医院[22]Department of Imaging Diagnostic, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College,[23]Qinghai University Affiliated Hospital, Xining[24]The First Affiliated Hospital of Chinese People’s Liberation Army General Hospital,[25]Zhejiang Cancer Hospital, Hangzhou浙江省肿瘤医院[26]Beijing Chest Hospital,Capital Medical University, Beijing,[27]Henan Province Cancer Hospital, Zhengzhou,河南省肿瘤医院[28]Shanxi Province Cancer Hospital, Taiyuan,[29]Nanfang Hospital, Nanfang Medical University, Guangzhou,[30]Cancer Hospital of Xinjiang Medical University, Urumqi,[31]Shanghai Pulmonary Hospital,Tongji University,[32]The First Affiliated Hospital, Zhejiang University, Hangzhou,浙江大学医学院附属第一医院[33]Xiangya Hospital, Central South University, Changsha,[34]Cancer Hospital, Fudan Universitay, Shanghai,[35]Fujian Cancer Hospital, Fuzhou, China
第一作者机构:[1]Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College,[*1]Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
通讯作者:
通讯机构:[1]Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College,[*1]Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
推荐引用方式(GB/T 7714):
Yuankai SHI,Yan SUN,Jinming YU,et al.China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version)[J].ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY.2017,13(1):87-103.doi:10.1111/ajco.12608.
APA:
Yuankai SHI,Yan SUN,Jinming YU,Cuimin DING,Ziping WANG...&Yu HUANG.(2017).China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version).ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY,13,(1)
MLA:
Yuankai SHI,et al."China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version)".ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 13..1(2017):87-103